Jie-Jun Wang
Overview
Explore the profile of Jie-Jun Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feng X, Hua Z, Zhou Q, Shi A, Song T, Qian D, et al.
BMJ Open
. 2021 Apr;
11(4):e042006.
PMID: 33827830
Objectives: To describe the prevalence of modifiable risk factors for upper digestive tract cancer (UDTC) and its coprevalence, and investigate relevant influencing factors of modifiable UDTC risk factors coprevalence among...
2.
Ye S, Deng D, Sun X, Wang J, Wang X
Guang Pu Xue Yu Guang Pu Fen Xi
. 2018 Jul;
36(5):1434-9.
PMID: 30001022
As a novel remote sensing technique, polarimetric detecting technology is a useful supplement to traditional hyperspectral remote sensing technology, which provides more information for remote sensing. By taking advantage of...
3.
Yu S, Wang J, Huang Y, Hu B, Wang K, Li P, et al.
J Glob Oncol
. 2017 Nov;
3(5):583-595.
PMID: 29094098
Purpose: The number of cancer cases in China has increased rapidly from 2.1 million in 2000 to 4.3 million in 2015. As a consequence, pain management as an integral part...
4.
Xie J, Li P, Gao H, Qian J, Yuan L, Wang J
BMC Gastroenterol
. 2014 Apr;
14:70.
PMID: 24712400
Background: Current literature has demonstrated that host glutamine depletion facilitates tumorigenesis. Likewise, the glutamine transporter SLC38A1 is putatively associated with malignant transformation and tumor progression. Taken together, this forms the...
5.
Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis
Liu Y, Gao S, Du B, Wang J
Tumour Biol
. 2013 Dec;
35(4):3551-61.
PMID: 24318992
The associations between IL-6 gene single nucleotide polymorphisms (SNPs) and risk of hepatocellular carcinoma (HCC) are controversial. We performed a meta-analysis to provide more credible evidence. We searched for relevant...
6.
Shen L, Xu J, Feng F, Jiao S, Wang L, Li J, et al.
Zhonghua Zhong Liu Za Zhi
. 2013 Aug;
35(4):295-300.
PMID: 23985260
Objective: To evaluate the efficacy and safety of trastuzumab in combination with chemotherapy versus chemotherapy alone in the first-line treatment of HER-2-positive advanced gastric or gastro-oesophageal junction cancer. Methods: Fifteen...
7.
Wang X, Huang C, Yu G, Wang J, Wang R, Li Y, et al.
Hum Pathol
. 2013 May;
44(10):2020-7.
PMID: 23664539
Growing evidence suggests that phospholipase A2 (PLA2) plays a pivotal role in tumorigenesis in human gastrointestinal cancer. One of the well-studied isoforms of PLA2, group IIA PLA2 (PLA2G2A), appears to...
8.
Zhang X, Wu Q, Gan L, Yu G, Wang R, Wang Z, et al.
Med Oncol
. 2013 Jan;
30(1):454.
PMID: 23307260
Arachidonic acid metabolic pathway has been implicated in the inflammation-associated tumorigenesis of gastrointestinal cancers. As the rate-limiting enzyme of arachidonic acid production, group IVA phospholipase A2 (PLA2G4A) is hypothesized to...
9.
Gan L, He J, Zhang X, Zhang Y, Yu G, Chen Y, et al.
BMC Cancer
. 2012 Dec;
12:566.
PMID: 23199240
Background: Increasing interest has been devoted to the expression and possible role of sex hormone receptors in gastric cancer, but most of these findings are controversial. In the present study,...
10.
Guan Z, Xu J, Luo R, Feng F, Wang L, Shen L, et al.
Chin J Cancer
. 2011 Oct;
30(10):682-9.
PMID: 21959045
The efficacy and safety of bevacizumab with modified irinotecan, leucovorin bolus, and 5-fluorouracil intravenous infusion (mIFL) in the first-line treatment of metastatic colorectal cancer (mCRC) has not been well evaluated...